Zolbetuximab, CAS 1496553-00-4

Product Description: Zolbetuximab (IMAB362) is a monoclonal antibody targeting Claudin-18.2. Zolbetuximab mediates specific killing of Claudin-18.2-positive cells through immune effector mechanisms. Zolbetuximab can be used for the research of gastrointestinal adenocarcinomas and pancreatic tumors[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Türeci Ӧ, et al. Characterization of zolbetuximab in pancreatic cancer models. Oncoimmunology. 2018 Nov 10;8(1):e1523096. /[2]Zhong W, et al. Development of a Humanized VHH Based Recombinant Antibody Targeting Claudin 18.2 Positive Cancers. Front Immunol. 2022 Jun 28;13:885424./[3]Kyuno D, et, al. Claudin-18.2 as a therapeutic target in cancers: cumulative findings from basic research and clinical trials. Tissue Barriers. 2022 Jan 2;10(1):1967080.

CAS Number: 1496553-00-4

Molecular Weight: N/A

Compound Purity: 96.98

Research Area: Cancer

Solubility: H2O

Target: Others

• Artikelnummer: MEXHY-P99058-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99058-5
• Green Labware: Nein
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK